Much of epidemiologic and social science research is devoted to estimation of causal effects and testing causal hypotheses using nonexperimental data. In such endeavors, issues of confounding will (or should) invariably arise. Unfortunately, the word "confounding" has been used to refer to at least three distinct concepts. In the oldest usage, confounding is a type of bias in estimating causal effects. This bias is sometimes informally described as a mixing of effects of extraneous factors (called confounders) with the effect of interest. This usage predominates in nonexperimental research, especially in epidemiology and sociology. In a second and more recent usage, "confounding" is a synonym for "noncollapsibility," although this usage is often limited to situations in which the parameter of interest is a causal effect. In a third usage, originating in the experimental-design literature, "confounding" refers to inseparability of main effects and interactions under a particular design. The term "aliasing" is also sometimes used to refer to the latter concept; this usage is common in the analysis-of-variance literature.
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The three concepts of confounding are not always distinguished properly. In particular, the concepts of confounding as a bias in effect estimation and as noncollapsibility are often treated as identical. We here provide an historical overview of these two concepts and the distinctions among them. Because these distinctions require a formal model for causal effects, we begin with a discussion of the counterfactual model of causation. We then trace the history of the concept of confounding from the writings of J. S. Mill to its modern counterfactual formalization. We discuss how approaches to control of confounding fit into this formalization; we give special attention to the relation of confounding to exchangeability and randomization. We then shift our focus to concepts of collapsibility and describe how the counterfactual model distinguishes noncollapsibility from confounding. Our penultimate section covers some miscellaneous issues that arise when considering confounding in studies of interventions. We end with a recommendation to include more thorough discussion of confounding in basic statistics education, given the importance of the concept in causal inference.
THE COUNTERFACTUAL APPROACH
TO CAUSE AND EFFECT
1.I Overview
The concepts of cause and effect are central to most areas of scientific research. Thus, it may be surprising that consensus about basic definitions and methods for causal inference is limited, despite some three centuries of debate. A brief review cannot do justice to all the history and details of this debate, nor to all the schools of thought on causation. We therefore focus on one conceptualization that has proved useful in the analysis of confounding. This counterfactual or potential-outcomes approach has become common in philosophy, statistics and epidemiology.
Since the early eighteenth century, philosophers noted serious deficiencies in common definitions of causation. For example, Webster's New TwentiethCentury Dictionary (1979) offered "that which produces an effect or result" as a definition of "cause," but "to cause" is among the definitions of "produces." Informal definitions of "effect" suffer from the same circularity, because "effect" as a verb is merely a synonym for "cause," while "effect" as a noun is defined as a "result," which is in turn defined as an "effect" in causal contexts. Hume (1739 Hume ( , 1748 offered another view of causation that pointed a way out of the circularity of common definitions:
We may define a cause to be an object, followed by another,. . .where, if the first object had not been, the second had never existed (Hume, 1748, page 115) .
Thus, by focusing on specific instances of causation, we say that an event A caused an event B if occurrence of A was necessary for occurrence of B under the observed background circumstances (e.g., see Simon and Rescher, 1966; Lewis, 1973a) . Essentially the same concept of causation can be found in the works of J. S. Mill (1843 S. Mill ( , 1862 and R. A. Fisher (1918) (both quoted in Rubin, 1990) , as well as in later works in statistics and related fields (Sobel, 1995) . A typical example is from MacMahon and Pugh (1967, page 12) , who state that ". . . an association may be classed as presumptively causal when it is believed that, had the cause been altered, the effect would have been changed" (italics added). The italicized phrases emphasize that the alteration of the antecedent condition ("cause") and the subsequent change in the outcome ("effect") are contrary to what was in fact observed; that is, they are counterfactual.
The preceding definition falls short of the formalism necessary for derivation of statistical methods for causal inference. Such a formalism and derivation first appeared in the statistics literature in Neyman (1923) . The basic idea is as follows: suppose that N units (e.g., individuals, populations, objects) are to be observed in an experiment that will assign each unit one of K + 1 treatments xo, X I , .. .,xK. The outcome of interest for unit i is the value of a response variable Yi. Suppose that Yi will equal yik if unit i is assigned treatment xh. Usually, one treatment level, say xo, is designated the reference treatment against which other treatments are to be evaluated; typically, xo is "no treatment," a placebo or a standard treatment. We define the causal effect of xk(k 1) on Yi relative to xo (the referent) to be yik -yio. (If the response variable is strictly positive, we may instead define the causal effect as yik/yio or log yih -log yio.) In words, a causal effect is a contrast between the outcomes of a single unit under different treatment possibilities.
Neyman's formalism is sometimes referred to as the potential-outcomes model of causation, and has reappeared in various guises (e.g., see Cox, 1958, Chapter 2; Copas, 1973; Rubin, 1974; Hamilton, 1979) . Defining effects as contrasts of potential outcomes yih gives precise meanings to words such as "cause," "effect," and "affect." For example, "changing X from xo to xk affects Yin is an assertion that yik-yio# 0. Note, however, that because only one of the potential outcomes yik can be observed in any one unit, an individual effect yik -yio cannot be observed.
Counterfactual analysis can be viewed as a special type of latent-variable analysis, in which yih remains latent for any individual i who did not receive treatment k (e.g., see the volume edited by Berkane, 1997) . The potential outcomes model can also be derived from a structural equations approach familiar in the social sciences. Here, one models the response variable Y as one output of a series of mechanisms, where each mechanism is an input-output device whose behavior follows a given equation (Simon and Rescher, 1966) . The potential response yik is then simply the solution for Y of the system of equations when X is "set" to xk; a change from xo to xk has no effect if X does not appear in the system, or more generally, if the solution is the same regardless of whether X is set to xo or xh (Balke and Pearl, 1994; Robins, 1995a; Pearl, 1995; Galles and Pearl, 1998) .
There are several crucial restrictions that the potential outcomes definition places on the notion of causal effects (and hence, cause). Appendix 1 discusses four of them in detail. In Appendix 2, we discuss some difficulties that arise in defining potential outcomes when competing risks are present.
Probabilistic Extensions
There are several probabilistic extensions of counterfactual approaches. One is based on considering the sampling distribution of fixed potential outcomes, that is, the joint distribution F(yo, . . . , yK) of yio, .. . , yiK in a population of units. We may 31 CONFOUNDING AND COLLAPSIBILITY IN CAUSAL INFERENCE also consider conditional distributions of potential outcomes in subpopulations defined by covariates such as age, sex and received treatment. Population effects can be defined as differences in average population response under different treatments, or more generally as differences among the marginal distributions F(yo),. . . , F(yK). Statistical procedures for inferences about these effects follow from randomization assumptions about treatment assignment mechanisms and from assumptions of independencies between units (Cox, 1958) . The basic ideas were developed by Neyman (1923) and Fisher (1935) ; some key elaborations were given by Copas (1973) and Rubin (1974 Rubin ( , 1978 . We will discuss these ideas below.
Another extension considers parameters of probability distributions (rather than events) as the potential outcomes; this extension addresses objections to treating the unit outcomes as deterministic entities once treatment is given (Greenland, 1987; Robins, 1988; Robins and Greenland, 1989) . For example, we could consider the difference between the probability that a given atom emits a photon in the second following absorption of a photon ("treatment 1")and the probability of emission in the same second if no photon had been absorbed ("treatment 0"). This probability difference is the effect of photon absorption on the atom relative to no absorption. In quantum mechanics, this probability difference (effect) is well defined whether or not a photon is actually emitted (e.g., see Feynman, 1963 ). Yet, according to the Bohr-Heisenberg ("Copenhagen") interpretation of quantum theory, the emission indicator (Yi= 1 if the atom emits a photon in the following second; 0 if not) is undefined under counterfactual alternatives to the actual history of the atom and is not even defined under the actual history of the atom if no emission measurement is made.
Objections to Counterfactuals
Counterfactual approaches are sometimes criticized because, in considering causes of past events, they invoke distributions for events that never occurred and hence cannot be observed. As a consequence, some important features of these distributions remain empirically untestable, and thus some causal inferences based on counterfactuals will depend entirely on untestable assumptions (Dawid, 1998) .
It is our view that this property of counterfactual inferences reflects a strength of counterfactual approach, rather than a weakness. It is an unfortunate but true fact that many important causal questions are simply not answerable, at least not without employing assumptions that are untestable given current technology, Examples of such assumptions include assumptions of no confounding, as discussed in the following sections, assumptions about independence of unit-specific susceptibilities or responses, and various distributional assumptions (Copas, 1973; Rubin, 1978 Rubin, , 1991 Holland, 1986; Heckman and Hotz, 1989; Robins and Greenland, 1989; Sobel, 1995; Rosenbaum, 1995; Copas and Li, 1997) . Inferences from counterfactual approaches properly reflect this harsh epistemic reality when they display sensitivity to such assumptions.
More constructively, the counterfactual approach also aids in precise formulation of assumptions needed to identify causal effects statistically, which in turn can aid in developing techniques for meeting those assumptions. The basic example on which we will focus is the assumption of exchangeability of response distributions under homogeneous treatment assignment, which is met when treatment is successfully randomized, or, more generally, when treatment assignment is independent of the potential outcomes y , k .
CONFOUNDING

Background
Counterfactual approaches to causal inference emphasize the importance of randomization in assuring identifiability of causal effects (Neyman, 1923; Rubin, 1978 Rubin, , 1990 Rubin, , 1991 Greenland and Robins, 1986; Robins, 1986; Greenland, 1990; Rosenbaum, 1995) . In observational studies, however, no such assurance is available, and issues of confounding become paramount.
One of the earliest systematic discussions of "con- It should be noted that, in Mill's time, the word "experiment" referred to an observation in which some circumstances were under the control of the observer, as it still is used in ordinary English, rather than to the notion of a comparative trial. Nonetheless, Mill's requirement suggests that a comparison is to be made between the outcome --of his experiment (which is, essentially, an uncontrolled trial) and what we would expect the outcome to be if the agents we wish to study had been absent. If the outcome is not that which one would expect in the absence of the study agents, his requirement insures that the unexpected outcome was not brought about by extraneous circumstances. If, however, those circumstances do bring about the unexpected outcome, and that outcome is mistakenly attributed to effects of the study agents, the mistake is one of confounding (or confusion) of the extraneous effects with the agent effects.
Much of the modern literature follows the same informal conceptualization given by Mill. Terminology is now more specific, with "treatment" used to refer to an agent administered by the investigator and "exposure" often used to denote an unmanipulated agent. The chief development beyond Mill is that the expectation for the outcome in absence of the study exposure is now almost always explicitly derived from observation of a control group that is untreated or unexposed. For example, Clayton and Hills (1993, page 133) As discussed below, confounding is also possible in randomized experiments, because of systematic elements in treatment allocation, administration, and compliance and because of random differences between comparison groups (Fisher, 1935, page 49; Rothman, 1977; Greenland and Robins, 1986; Greenland, 1990) .
Formalization
Attempts to quantify the above notion of confounding can be traced at least as far back as the work of Karl Pearson and George Yule on spurious correlation, but these attempts ran afoul of the absence of a formal model for causal effects; see Aldrich (1995) for a review of this work. Various mathematical formalizations of confounding have since been proposed. Perhaps the one closest to Mill's concept is based on the counterfactual model for effects. Suppose our objective is to determine the effect of applying a treatment or exposure xl on a parameter p of the distribution of the outcome y in population A, relative to applying treatment or exposure xo. That is, we wish to contrast the marginal distributions FA(yl) and FA(yO) of the potential outcomes under treatments 1and 0, using some parameter (summary) p of the distributions. For example, population A could be a cohort of breast-cancer patients, treatment xl could be a new hormone therapy, xo could be a placebo therapy, and the parameter p could be the expected survival or the five-year survival probability in the cohort; p could also be a vector or even a function, such as an entire survival curve. The population A is sometimes called the target population or index population; the treatment xl is sometimes called the index treatment and the treatment xo is sometimes called the control or reference treatment.
Suppose that p will equal pA1if x1 is applied to population A, and will equal pAoif x0 is applied to that population; the causal effect of xl relative to xo is defined as the change from pAO to pA1, which could be measured by pAl-pAO if (or by pA1/pAO p is strictly positive). If A is observed under treatment xl, p will equal pA1, which is observable or estimable, but pAowill be unobserved. Suppose, however, we expect pAO to equal pBo, where pBO is the value of the outcome p observed or estimated for a population B that was administered treatment xo. The latter population is sometimes called a control or reference population. We say confounding is present if, in fact, pAo# pBo, for then there must be some difference between populations A and B (other than treatment) that is responsible for the discrepancy between pAoand pBo.
If confounding is present, a naive (crude) association parameter obtained by substituting pBO for pAoin the effect measure will not equal the causal parameter, and the association parameter is said to be confounded. For example, if pBO # pAo, then pAl-pBo, which measures the association of treatments with outcomes across the populations, is confounded for pA1-pAo, which measures the effect of treatment xl on population A. Thus, saying an association parameter such as pAl -pBo is confounded for a causal parameter such as pA1 -pAois synonymous with saying the two parameters are not equal.
The above formalization has several interesting implications. One is that confounding depends on the outcome parameter. For example, suppose populations A and B would have different five-year survival probabilities pAO and pBounder placebo treatment xo, so that pA1-pBO is confounded for the actual effect pA1-pAO of treatment on fiveyear survival. It is then still possible that ten-year survival v under the placebo would be identical in both populations; that is, vAo could still equal vBo, SO that vAl -vBo is not confounded for the actual effect of treatment on ten-year survival. (We should generally expect no confounding for 200-year survival, because no treatment is likely to raise the 200-year survival probability of human patients above zero.)
Another important implication is that confounding depends on the target population of inference.
The preceding example, with A as the target, had different five-year survivals pAoand pBofor A and B under placebo therapy, and hence pA1-pBO was confounded for the effect pA1-pAO of treatment on population A. A lawyer or ethicist may also be interested in what effect the treatment would have had on population B. Writing pB1for the (unobserved) outcome of B under treatment, this effect on B may be measured by pB1-pBo. Substituting pA1for the unobserved pB1yields pA1-pBo. This measure of association is confounded for pB1-pBO (the effect of treatment xl on five-year survival in population B) if and only if pAl # pB1.Thus, the same measure of association pAl -pBomay be confounded for the effect of treatment on neither, one or both of populations A and B.
A third implication is that absence of confounding (pAO = pBO), which is a population condition, is not sufficient to identify the sharp null hypothesis of no causal effects at the unit level (yil = yiofor all units i) because causal effects of treatment may cancel out . For example, suppose the outcome parameter p is expected response and response is binary, with half of units in A and half in B having yil = 1, yio = 0 and half having yil = 0, yio = 1. Then pA1= pAo= pBo= 112, SO that there is no confounding and no identifiable effect of treatment on the outcome distribution; nonetheless, every unit is affected by treatment. Neyman (1935) and Stone (1993) make the analogous point that randomization does not identify the sharp null hypothesis.
A noteworthy aspect of the above definition of confounding is that it does not involve the notion of probabilistic independence, and makes no reference to individual units or probability distributions other than through the summary p. This is in sharp contrast to concepts of randomization, exchangeability and ignorability, as well as certain definitions of "no confounding," which we will discuss in Sections 3.1, 3.3 and 6.4.
Components of Associations
We may write the difference in the outcome parameters of populations A and B as which shows that ~A~-/ L B O is a mix of the true treatment effect pA1-pAO and a bias term pAo-pBo (Groves and Ogburn, 1928; Kitagawa, 1955) . Nonidentifiability of the true effect pA1-pAofollows if the bias pAo-pBois not identifiable, as is the case in typical epidemiologic studies .
By rearranging (1)we may obtain pAO -pBO as a measure of confounding in pAl-pBO: When the outcome parameters p are risks (probabilities), epidemiologists use instead the analogous ratio as a measure of confounding (Cornfield et al., 1959; Bross, 1967; Miettinen, 1972) ; pAO/pBO someis times called the confounding risk ratio. The latter term is somewhat confusing, as it is sometimes misunderstood to refer to the effect of a particular confounder on risk. This is not so, although the ratio does reflect the net effect of the differences in the confounder distributions of populations A and B.
Confounders
The above formalization of confounding invokes no explicit differences (imbalances) between populations A and B with respect to circumstances or covariates that might affect p . It seems intuitively clear that, if pAo and pBo differ, then A and B must differ with respect to factors that affect p. This intuition has led some authors to define confounding in terms of differences in covariate distributions among the compared populations (e.g., Stone, 1993) . Nonetheless, confounding as we have defined it is not an inevitable consequence of covariate differences; A and B may differ profoundly with respect to covariates that affect p, and yet confounding may be absent. In other words, a covariate difference between A and B is a necessary but not sufficient condition for confounding, because the effects of the various covariate differences may balance out in such a way that no confounding is present.
Suppose now that populations A and B differ with respect to certain covariates that affect p and that these differences have led to confounding of an association measure for the effect measure of interest. The responsible covariates are then termed "confounders" of the association measure. In the above example, with pA1-pBoconfounded for the effect p~1 -pAo, the factors that led to pAo# pBo are the confounders. A variable cannot be a confounder (in this sense) unless (1) it can causally affect the outcome parameter p within treatment groups, and (2) it is distributed differently among the compared populations (e.g., see Yule, 1903 , who however uses terms such as "fictitious association" rather than "confounding"). The two necessary conditions (1)and (2) are sometimes offered together as a definition of a confounder. Nonetheless, counterexamples show that the two conditions are not sufficient for a variable with more than two levels to be a confounder as defined above; one such counterexample is given below.
While definitions of "confounder" similar to that just given are common in epidemiology texts (e.g., see Kelsey, Whittemore, Evans and Thompson, 1996; Rothman and Greenland, 1998) , they are not universal. Some authors (e.g., Miettinen and Cook, 1981; Robins and Morgenstern, 1987) define a confounder more broadly, as any variable for which adjustment is helpful in reducing bias in effect estimation; variables that are confounders by virtue of their effects on the outcome parameter are then called causal confounders. Such broad definitions of confounders stem from recognition that confounding may be dealt with by stratification on variables that are not themselves causes of the outcome. Examples include surrogates for such causes (Kelsey et al., 1996) and determinants of treatment (Rosenbaum and Rubin, 1983) .
Regression Formulations
For simplicity, the above presentation has focused on comparing two groups and two treatments. The basic concepts extend immediately to consideration of multiple groups and treatments. Pairwise comparisons may be represented using the above formalization without modification. Although the comparisons may be made nonparametrically, it is instructive to examine their representation in terms of familiar regression models.
As an illustration, suppose that the treatment level x may range over a continuum or a multidimensional space (in the latter case x and p are row and column vectors), and that population j is given treatment x j, even though it could have been given some other treatment. Under the causal model (4) pj(x) = a j + xp for all j, the absolute effect of xl versus xo on p in population 1is
In the earlier notation, j = A, B, so that p1(x1) was pA1 and p1(xO) was pAO.) Substitution of po(xo), the value of p in population 0 under treatment xo, for pl(xo) yields which is biased by the amount Thus, under this model, no confounding for P will occur if the intercepts a j are constant across populations, so that pj(x) = a + xP.
When constant intercepts cannot be assumed and nothing else is known about the intercept magnitudes, it may be possible to represent our uncertainty about a via the mixed effects model Here, a j has been decomposed into a + ej, where c j has mean zero, and the confounding in pl(xl) -po(xo) has become an unobserved random variable -EO. Correlation of the random effects ( E~) with the treatments (xj) leads to bias in estimating p. This bias may be attributed to or interpreted as confounding for j 3 in the regression analysis. Confounders are now covariates that "explain" the correlation between E and x j. In particular, confounders reduce the correlation of x j and c j when entered in the model and so reduce the bias in estimating p.
CONTROL OF CONFOUNDING
Control Via Design
Perhaps the most obvious way to avoid confounding in estimating pAl-pAO is to obtain a reference population B for which ~. L B O is known to equal pAo. Among epidemiologists, such a population is sometimes said to be comparable to or exchangeable with A with respect to the outcome under the reference treatment. In practice, such a population may be difficult or impossible to find. Thus, an investigator may attempt to construct such a population, or to construct exchangeable index and reference populations. These constructions may be viewed as designbased methods for the control of confounding.
Restriction and matching. Perhaps no approach is more effective for preventing confounding by a known factor than restriction. For example, gender imbalances cannot confound a study restricted to Women. Nonetheless, restriction on many factors can reduce the number of available subjects to unacceptably low levels and may greatly reduce the generalizability of results as well. Matching the treatment populations on confounders overcomes these drawbacks and, if successful, can be as effective as restriction. For example, gender imbalances cannot confound a study in which the compared groups have identical proportions of women. Unfortunately, differential losses to observation may undo the initial covariate balances produced by matching. Another problem is that matches may become difficult or impossible to find if one attempts to match on more than a few factors.
Randomization. Neither restriction nor matching prevents (although they may diminish) imbalances on unrestricted, unmatched or unmeasured covariates. In contrast, randomized treatment allocation (randomization) offers a means of dealing with confounding by covariates not explicitly accounted for by the design. It must be emphasized, however, that this solution is only probabilistic and subject to severe practical constraints. For example, protocol violations and loss to follow-up may produce systematic covariate imbalances between the groups (and consequent confounding), and random imbalances may be severe, especially if the study size is small (Fisher, 1935; Rothman, 1977) . Blocked randomization can help ensure that random imbalances on the blocking factors will not occur, but it does not guarantee balance of unblocked factors. Thus, even in a perfectly executed randomized trial, the noconfounding condition pAo= pBois not a realistic assumption for inferences about causal effects. Successful randomization simply insures that the difference pAo-pBo, and hence the degree of confounding, has expectation zero and converges to zero under the randomization distribution; it also provides a permutation distribution for causal inferences (Fisher, 1935; Cox, 1958, Chapter 5) .
Exchangeability. Under randomization, the parameters pAoand pBo(and pA1and pBlas well) are outcomes of a random process and so can be treated as random variables. Successful randomization renders pAo and pBOunconditionally exchangeable in the usual probabilistic sense (Cornfield, 1976) ; in other words, the unconditional joint distribution FO(uA, uB) of pAo, pBois symmetric, so that FO(uA, uB) = FO(uB, uA) for any possible pair of values UA,UB for pAo, p B OThis exchangeability permits derivation of inferential procedures for (say) pA1-pAobased on substituting pBofor pAo and then allowing for random differences between pAO and pBo (Robins, 1988) . It applies regardless of what the parameter p represents; that is, randomization yields exchangeability for all parameters of the outcome distribution. From a Bayesian perspective, pAoand pBo can always be treated as random variables. Thus, a practical and sufficient design-based approach to confounding is to find or construct comparison groups such that pAO and pBo are exchangeable. Now consider the regression formulation (8). Here again, it is neither realistic nor necessary to assume absence of confounding to make inferences about the effect parameter p. Rather, it is sufficient to find a population such that the random effects c j are exchangeable (so that any correlation of x j and c j is random), as would arise if treatment levels were randomized. This approach is often described in epidemiology as searching for a "natural experiment," that is, a situation in which a compelling argument can be made that the exposure was effectively randomized by natural circumstances. Of course, any inferences may be sensitive to assumptions about the distribution of the random effects (e.g., normality), and the structural form of the model (e.g., linearity); such concerns lead naturally to randomization tests for effects (Fisher, 1935; Cox, 1958; Copas, 1973) .
Control Via Analysis
Design-based methods are often infeasible or insufficient to produce exchangeability. Thus, there has been an enormous amount of work devoted to analytic adjustments for confounding. With a few exceptions, these methods are based on observed covariate distributions in the compared populations. Such methods will successfully control confounding only to the extent that enough confounders are adequately measured and employed in the analysis. Then, too, many methods employ parametric models at some stage, and their success thus depends on the faithfulness of the model to reality. There is a tension between the demands of adjusting for enough covariates and the dependence of the analysis on modeling assumptions. This issue cannot be covered in depth here, but a few basic points are worth noting.
The simplest methods of adjustment begin with stratification on confounders. A covariate cannot be responsible for confounding within a stratum that is internally homogeneous with respect to the covariate. This is so, regardless of whether the covariate was used to define the stratum. For example, gender imbalances cannot confound observations within a stratum composed solely of women. It would seem natural, then, to control confounding due to measured factors by simply stratifying on them all. Unfortunately, one would then confront the well-known sparse-data problem: given enough factors, few if any strata would have subjects in both treatment groups, thereby making comparisons inefficient or impossible .
One solution to this problem begins by noting that within-stratum homogeneity is unnecessary to prevent confounding by a covariate. Within-stratum balance is sufficient, because comparisons within a stratum cannot be confounded by a covariate that is not associated with treatment within the stratum. Hence, a given stratification should be sufficient to control confounding by a set of covariates if the covariates are balanced across the strata, that is, unassociated with treatment within the strata. Rosenbaum and Rubin (1983) showed that, subject to any modeling restrictions used for score estimation, balance in probability for a set of covariates could be achieved by exact stratification on the estimated propensity score, where the propensity score is defined as the probability of treatment given the covariates in the combined (treated and untreated) study population. They further showed that this score was the coarsest score that would produce balance in probability. Stratification on the estimated propensity score thus reduces adjustment for multiple covariates to stratification on a single variable and lowers the risk of sparse-data problems if the model used for propensity scoring is correct. Unfortunately, in sparse data there may be little power to test whether the model is correct.
The most common method for avoiding sparsedata problems is to impose parametric constraints on the regression of the outcome on the treatment and covariates; such strategies are described in many textbooks (e.g., see Clayton and Hills, 1993; Kelsey et al., 1996; Rothman and Greenland, 1998) . Hybrid methods which combine regressions on treatment and outcome have also been developed; see Robins and Greenland (1994) and Rosenbaum (1995) for examples. Nonetheless, theoretical results indicate that no approach can completely solve sparse-data problems, insofar as sample size will always limit the number of degrees of freedom available for covariate adjustment and model testing (Robins and Ritov, 1997) .
Sufficient Control
Without randomization, the evaluation of withinstratum or residual confounding becomes a major concern. For this purpose, we define a stratification as sufficient for estimation of stratum-specific causal effects if, within strata, ~A O and p~~ are exchangeable. In a parallel fashion, we define a set of variables as sufficient for control of confounding if simultaneous (joint) stratification on all the variables is sufficient in the sense just described. (We note in passing that this is a weaker condition than that of "covariate sufficiency" as used in Stone, 1993.) Randomization ensures sufficiency of the set of measured variables not affected by treatment. In the absence of randomization, however, causal inferences become dependent on and sensitive to the assumption that the set of variables available for analysis is sufficient. It almost always remains logically possible that this set is insufficient because some confounder essential for sufficiency has not been recorded; thus, causal inferences from observational studies almost always hinge on subject-matter priors ("judgements") about what may be missing from the set. Sensitivity of results to possible unmeasured confounders can be assessed via formal sensitivity analysis (Rosenbaum, 1995; Copas and Li, 1997; Robins, Rotnitzky, and Scharfstein, 1999) .
There are some systematic ways of deriving the implications of background assumptions. For example, assumptions about the directions and absences of causal relations among variables (measured and unmeasured) can be conveniently encoded in a causal graph or path diagram, in which arrows (directed arcs) represent cause-effect relations. Conditional on the assumptions underlying the graph, the question of sufficiency of a set of variables (such as the set of measured variables) can be easily answered using a simple graphical algorithm called the "back-door test" (Pearl, 1995) . The same algorithm allows one to determine whether subsets of a sufficient set are themselves sufficient. By stepwise deletion and testing, we may thus identify minimally sufficient subsets (that is, sufficient subsets with no sufficient proper subsets). The need for such identification arises, for example, in epidemiologic studies in which numerous "lifestyle" covariates (diet, physical activity, smoking and drinking habits, etc.) are measured and are potential confounders of the effect under study. Here, the total set of covariates may be sufficient for control as defined above, but impractical to control in its entirety, even when using propensity score or outcome-regression methods (Greenland, Pearl and Robins, 1999) .
Graphical identification of sufficient subsets operates on background assumptions, rather than data. An analogous statistical approach is given by the following result (Robins, 1997) .
THEOREM. A subset S of a sufficient set is itself sufficient if the remainder subset R (those variables i n the original set but not i n S ) can be decomposed into disjoint subsets R 1 and R 2 such that both (9) R I U X I S and R 2 U Y I R 1 , X , S ; that is, R 1 is independent of treatment X given S , and R 2 is independent of the outcome Y given R1, treatment X , and S . When such a decomposition exists, R 1 can be taken to be the largest subset of R satisfying R 1 11 X I S .
Any set identified as sufficient by the back-door test must satisfy the conditions of Robins's theorem, although the converse is not true (Robins, 1997) . As an example of the theorem, suppose X is measured breast-implant exposure, Y is time to breast cancer from an index time, S contains diet and exercise variables, R contains alcohol-drinking and smoking variables with R1 = drinking and R2 = smoking variables, and SU R is sufficient. Then the drinking and smoking variables can be omitted if the drinking and implant variables are independent conditional on the diet and exercise variables, and the smoking and breast cancer variables are independent conditional on the drinking, implant, diet and exercise variables. These conditions are testable using observed data; for example, smoking has not been found to be associated with breast cancer upon extensive control of other lifestyle variables, while the association of drinking and implants could be examined in certain existing data bases.
Stone (1993, page 459) defined "no confounding given S" as fulfillment of the above condition (9) with R1 equal to all unobserved covariates that affect the response (outcome). This "no-confounding" definition neither implies nor is implied by our definition, but Stone showed that it does imply that S is sufficient for control. The above theorem is a generalization of Stone's result, in that it imposes no causal constraints on R1 or R2; for example, it does not assume that R1 contains all (or even any) covariates that affect response.
A set S that is sufficient for estimating stratumspecific effects will also be sufficient for estimating a summary measure of the effect of treatment on the entire target population. Nonetheless, because confounding may "average out" across strata, the converse is not true: a set S may be sufficient for estimating a summary effect even though insufficient for estimating stratum-specific effects (Greenland and Robins, 1986) . This notion will be formalized in the next subsection.
Residual Confounding
Suppose that we subdivide the total study population (A + B) into K strata indexed by k. Let p~l k be the parameter of interest in stratum k of populations A and B under treatment xl. The effect of treatment xl relative to xo in stratum k may be defined as p~l k -p~o k Or pAlk/pAOk. The Confounding that remains in stratum k is called the residual confounding in the stratum, and is measured by p~o k -01. pAOk/pBOk. p~o k Note that a sufficient stratification has E(pAOk -pBOk) = 0 for all k by virtue of the exchangeability of pAok and p~o k , yet may have random residual confounding within strata.
Residual confounding may be summarized in a number of ways, for example, by standardization or other weighted-averaging methods (Miettinen, 1972; Rothman and Greenland, 1998) . As an illustration, suppose the strata represent age-sexspecific subgroups, and the proportion of the standard population that falls in age-sex stratum k is pk. Then the effect of xl versus xo on A standardized to (weighted by) the distribution pl, . . . ,pK is whereas the standardized difference comparing A to B is
The overall residual confounding in DAB is thus which may be recognized as the standardized difference comparing A and B when both are given treatment xo, using pl, . . . ,p K as the standard distribution. With this formulation, a stratification can be considered sufficient for inference on DAA if C PkpAok and C I, PkpBok are exchangeable.
COLLAPSIBILITY
Collapsibility in Contingency Tables
Consider the I x J x K contingency table representing the joint distribution of three discrete variables X , Y, Z, the I x J marginal table representing the joint distribution of X and Y, and the set of conditional I x J subtables (strata) representing the joint distributions of X and Y within levels of Z. Generalizing Whittemore (1978) (who considered log-linear model parameters), we say a measure of association of X and Y is strictly collapsible across Z if it is constant across the strata (subtables) and this constant value equals the value obtained from the marginal table.
Noncollapsibility (violation of collapsibility) is sometimes referred to as Simpson's paradox, after a celebrated article by Simpson (1951) . This phenomenon had been discussed by earlier authors, including Yule (1903) ; see also Cohen and Nagel (1934) . Some statisticians reserve the term Simpson's paradox to refer to the special case of noncollapsibility in which the conditional and marginal associations are in opposite directions, as in Simpson's numerical examples. Simpson's algebra and discussion, however, dealt with the general case of inequality. The term "collapsibility" seems to have arisen in later work; see Bishop, Fienberg and Holland (1975) . Table 1provides some simple examples. The difference of probabilities that Y = 1 (the risk difference) is strictly collapsible. Nonetheless, the ratio of probabilities that Y = 1 (the risk ratio) is not collapsible because the risk ratio varies across the Z strata, and the odds ratio is not collapsible because its marginal value does not equal the constant conditional (stratum-specific) value. Thus, collapsibility depends on the chosen measure of association. Now suppose that a measure is not constant across the strata, but that a particular summary of the conditional measures does equal the marginal measure. This summary is then said to be collapsible across Z . As an example, in Table 1the ratio of risks standardized to the marginal distribution of Z is equal to the marginal (crude) risk ratio. Thus, this measure is collapsible in Table 1 . Various tests of collapsibility and strict collapsibility have been developed; see Whittemore (1978) ; Asmussen and Edwards (1983) ; Ducharme and LePage (1986) ; Greenland and Mickey (1988) and Geng (1989) for examples.
Regression Formulation
The above definition of strict collapsibility extends to regression contexts. Consider a generalized linear model for the regression of Y on three regression vectors W, X, Z :
The regression is said to be collapsible for -/3 over Z if -/3 = -p* in the regression omitting Z, and is noncollapsible if P # P* (Clogg, Petkova and Shihadeh, 1992) . Thus, if theregression is collapsible for /3 over Z and P is the parameter of interest, Z need not be measured to estimate p. If Z is measured, however, tests of p = P* can be constructed (Hausman, 1978; Clogg PetTkova and Shihadeh, 1992; Clogg, Petkova and Haritou, 1995) .
The preceding definition generalizes the original contingency table definition to arbitrary variables. There is a technical problem with the above regression definition, however: If the first (full) model is correct, it is unlikely that the second (reduced) regression will follow the given form; that is, most families of regression models are not closed under deletion of Z. If, for example, Y is Bernoulli and g is the logit link function, so that the full regression is first-order logistic, the reduced regression will not follow a first-order logistic model except in special cases. One way around this dilemma (and the fact that neither of the models is likely to be exactly correct) is to define the model parameters as the asymptotic means of the maximum-likelihood estimators. These means are well defined and interpretable even if the models are not correct (White, 1994) .
It may be obvious that, if the full model is correct,
-6 = 0 implies collapsibility for P and y over Z. Suppose, however , that neither p nor 3 i s zero. In that case, marginal independenceof the regressors does not ensure collapsibility for /3 over Z except when g is the identity or log link (Ggil, Wieand and Piantadosi, 1984; Gail, 1986) ; conversely, collapsibility can occur even if the regressors are associated (Whittemore, 1978) ; see the example below. Thus, it is not generally correct to equate collapsibility over Z with simple independence conditions, although useful results are available for the important special cases of linear, log-linear, and logistic models (e.g., see Gail, 1986; Wermuth, 1987 Wermuth, , 1989 Robinson and Jewell, 1991; Geng, 1992; Guo and Geng, 1995) .
Other Collapsibility Concepts
The literature on graphical probability models distinguishes a number of properties that have been referred to as types of collapsibility; see Frydenberg (1990) , Whittaker (1990, Section 12.5) and Lauritzen (1996, Section 46 .1) for examples. Both definitions given above are special cases of parametric collapsibility (Whittaker, 1990) .
CONFOUNDING AND NONCOLLAPSIBILITY
The Divergence
Much of the statistics literature does not distinguish between the concept of confounding as a bias in effect estimation and the concept of noncollapsibility; for example, Becher (1992) defines confounding as p # p* in models (13) and (14), in which case the elemenG of Z are called confounders; similarly, Guo and Geng (1995) define Z to be a nonconfounder if P = P*. Nonetheless, the two concepts are distinct: confounding may occur with or without noncollapsibility and noncollapsibility may occur with or without confounding (Miettinen and Cook, 1981; Greenland and Robins, 1986; Wickramaratne and Holford, 1987) . Mathematically identical conclusions have been reached by other authors, albeit with different terminology in which noncollapsibility corresponds to "bias" and confounding corresponds to "covariate imbalance" (Gail, 1986; Hauck, Neuhaus, Kalbfleisch and Anderson, 1991) .
Noncollapsibility without confounding. Table 2 gives the response distributions under treatments xl and xo for a hypothetical target population A and the response distribution under treatment xo for a hypothetical reference population B. Suppose A receives treatment xl, B receives xo, and we wish to estimate the effect that receiving xl rather than xo had on A. If we take the odds of response as the outcome parameter p, we get pA1= 0.6/(1 -0.6) = 1.50, and pAo = pBo = 0.4/(1 -0.4) = 0.67. Hence, there is no confounding of the odds ratio: The preceding example illustrates a peculiar property of the odds ratio as an effect measure: treatment xl (relative to x0) elevates the odds of response by 125% in population A, yet within each stratum of Z it raises the odds by 167%. If Z is associated with response conditional on treatment but unconditionally unassociated with treatment, the stratum-specific odds ratios must be farther from 1than the unconditional odds ratio if the latter is not 1 (Gail, 1986; Hauck et al., 1991) . This phenomenon is often interpreted as a "bias" in the unconditional odds ratio, but in fact there is no bias if one takes care to not misinterpret the unconditional effect as an estimate of the stratum-specific or individual effects (Miettinen and Cook, 1981; Greenland, 1987) .
Confounding without noncollapsibility. To create a numerical example in which the odds ratio is collapsible and yet is confounded for the overall effect, we need only modify Table 2 slightly, by changing the stratum size for Z = 0 in population B to 1,500.
With this change, the proportion with Z = 1in population B drops from 0.5 to 0.4, the unconditional response probability in population B under treatment xo becomes 0.4(0.6)+0.6(0.2) = 0.36, and the unconditional response odds pBoin population B under xo becomes 0.36/(1 -0.36) = 0.5625. Thus, /LBO = 0.5625 < 0.67 = ~A O , with consequent confounding of the odds ratio: pA1/pAO, the true effect that xl had on the odds in population, equals 2.25 (as before), which is less than the unconditional odds ratio pA1/pBO1.50/0.5625 2.67. Nonetheless, this = = unconditional odds ratio equals the stratum-specific odds ratios, which are unchanged from the previous example.
Conditions for Equivalence
More generally, consider a situation in which the
The example in Table 2 shows that, when p is the odds of the outcome, pAO may equal /LBO (no confounding) even when the odds ratio is not collapsible over the confounders. Conversely, the modified example shows that we may have pAO # /LBO even when the odds ratio is collapsible. A probabilistic explanation of the discrepancy between nonconfounding and collapsibility is that pAOwill equal /LBO whenever Z is sufficient for control and is unconditionally unassociated with treatment, as in Table 2, whereas collapsibility of the odds ratio will occur whenever Z is unassociated with treatment conditional on response, as in the modified example (Bishop, Fienberg and Holland, 1975) . Thus, the discrepancy is just a consequence of the nonequivalence of unconditional and conditional associations.
If the effect measure is the difference or ratio of response proportions, results of Gail (1986) imply that this measure will be collapsible over Z if Z has the same distribution in A and B (that is, if Z and treatment are unconditionally unassociated). It follows that, when examining such measures, the above phenomena (noncollapsibility without confounding and confounding without noncollapsibility) cannot occur if Z is sufficient for control. More generally, when the effect measure can be expressed as the average effect on population members [e.g., under the linear causal model (4)1, the conditions for noncollapsibility and confounding will be identical, provided the covariates in question form a sufficient set for control. In such cases, noncollapsibility and confounding become equivalent, which may explain why the two concepts are often not distinguished. The nonequivalence of the two concepts for odds ratios simply reflects the fact that the unconditional effect of a treatment on the odds is not the average treatment effect on population members (Greenland, 1987) .
Regression Formulations
The preceding conclusions correspond to wellknown results for correlated-outcome regression. For example, the difference between the stratumspecific and crude odds ratios in Table 2 corresponds to the differences between cluster-specific and population-averaged (marginal) effects in binary regression (Neuhaus, Kalbfleisch and Hauck, 1991) : the clusters of correlated outcomes correspond to the strata, the cluster effects correspond to the covariate effects, the cluster-specific treatment effects correspond to the stratum-specific log odds ratios, and the population-averaged treatment effect corresponds to the crude log odds ratio.
full regression model [model (13)l is intended to represent causal effects of the regressors on Y. Noncollapsibility over Z (that is, P # P*) does not correspond to confounding of effects-unless g is the identity or log link. That is, it is possible for P to unbiasedly represent the effect of manipulating W within levels of X and Z, and, at the same time, for p* to unbiasedly represent the effect of manipulating W within levels of X , even though P* # P. Table 2 demonstrates this point for logistic mode& and shows that noncollapsibility in a logistic model does not always signal a bias. The divergence between /3 and p* corresponds to the distinction between d~ster-<~ecific and population-averaged effects: the cluster-specific model corresponds to the full model (13) in which Z is an unobserved univariate cluster-specific random variable independent of -W and X,with mean zero and unit variance; 42 is then the vector of random-effects variances.
CONFOUNDING IN INTERVENTION STUDIES: FURTHER ISSUES
In this section we briefly discuss some special issues of confounding that arise in studies of interventions, such as clinical trials and natural experiments.
Adjustment in Randomized Trials
Some controversy has existed about adjustment for random covariate imbalances in randomized trials. Although Fisher asserted that randomized comparisons were "unbiased," he also pointed out that they could be confounded in the sense used here (e.g., see Fisher, 1935, page 49 ). Fisher's use of the word "unbiased" was unconditional on allocation, and therefore of little guidance for analysis of a given trial. Some arguments for conditioning on allocation are given in Greenland and Robins (1986) and Robins and Morgenstern (1987) . Other arguments for adjustment in randomized trials have been given by Rothman (1977) ; Miettinen and Cook (1981) and Senn (1989) .
Intent-to-Treat Analysis
In a randomized trial, noncompliance can easily lead to confounding in comparisons of the groups actually receiving treatments xl and xo. One somewhat controversial solution to noncompliance problems is intent-to-treat analysis, which defines the comparison groups A and B by treatment assigned rather than treatment received. Detractors of intent-to-treat analysis consider it an attempt to define away a serious problem, es-pecially when treatment received is the treatment of scientific interest. Supporters of intent-to-treat analysis emphasize that intent-to-treat tests (tests of assigned-treatment effects) remain valid tests of received-treatment effects under broader conditions than conventional tests of received-treatment effects. See the volume edited by Goetghebeur and van Houwelingen (1998) for discussions of these and related issues, including alternatives to intent-to-treat analysis.
A crucial point is that confounding can affect even intent-to-treat analyses. For example, apparently random assignments may not be random, as when blinding is insufficient to prevent the treatment providers from protocol violations or when there is differential loss to follow-up. Even when these problems do not occur, random imbalances remain possible. A more subtle problem is that noncompliance can produce bias away from the null in an intent-to-treat analysis of equivalence trials. With noncompliance, the sharp null hypothesis (of equivalence of the two treatments) does not by itself imply that the distribution of outcomes will be the same in both treatment arms, because noncompliance represents movement into a third untreated state that does not correspond to any assigned treatment (Robins, 1998) . To illustrate, suppose treatments A and B are both 100% effective and thus completely equivalent with respect to their effect on the outcome, so that the equivalence null is satisfied. Suppose, however, that treatment A causes a harmless but unpleasant flushing sensation, whereas treatment B does not, and as a consequence compliance is 70% for A but 100% for treatment B. Then the intent-to-treat test will reject the null hypothesis of equivalence solely because of the lower compliance with treatment A.
Thus, in this example, noncompliance confounds the intent-to-treat analysis away from the correct null hypothesis of equivalence.
Choice of Target
In observational epidemiologic studies, the usual goal is to estimate the effect that treatment had on the treated group, pAl -pAo, or would have had on the untreated group, pB1-pBo, depending on the ultimate policy objectives; for example, pAl-pAo may be of interest as a measure of harm caused by the treatment. However, in randomized trials there are several reasons for orienting the estimation goal toward comparison of the expected outcome of the entire (treated + untreated) study group if everyone had been treated, p+l = (pA1+ pB1)/2, and the expected outcome of this group if no one had been treated, p += (pAO + pB0)/2 (Robins, 1988) . Both these outcomes are counterfactual, and so analysis requires substituting the estimable pair (pAl, pBO) for ( P +~, P +~) . Consequently, the no-confounding condition becomes pA1= p+l and /LBO = p +õr, equivalently, pAl= p~1 and pAo= /LBO. This condition is not realistic, but it is also not necessary. Inferential procedures for (say) p+l -p +can be derived from the randomization-induced unconditional exchangeability of pA1 with p~1 and of pAo with /LBO.
One advantage of focusing on p+l -p +rather than pA1 -pB1 is that standard inferential procedures for treatment effects on risks yield conservatively valid inferences for p+l -p + (Copas, 1973; Robins, 1988; see also Neyman, 1935) . Another argument for focusing on p+l and p +~ applies if the entire cohort is a random sample from a specified target population: in that situation p+l -p +will in expectation be closer to the treatment effect in the target than p~1 -pBO, because the former will deviate from the target effect only because of sampling variability, whereas the latter will incorporate randomization variability as well (Robins, 1988) .
lgnorability and Confounding
It is sometimes possible to evaluate a treatmentassignment mechanism even though the mechanism is not under control; examples include the way utility companies assign water and power sources to homes. In these settings, the mechanism may clearly not be random but may nonetheless satisfy weaker conditions that allow inferences about the effect of interest.
As an example, suppose one is interested in just one particular outcome variable, such as time to death. A treatment-assignment mechanism is strongly ignorable for the outcome variable if (1) the treatment-assignment variable X it defines is independent of the vector y = (yo,y l , . . . ,yK ) of potential outcomes, and (2) each unit has nonzero probability of assignment to each treatment level (Rosenbaum and Rubin, 1983) . Standard randomization methods are strongly ignorable for all outcomes when noncompliance and censoring are absent or purely random.
Like randomization, strongly ignorable treatment assignment insures that parameters of the population-specific distributions of potential outcomes will be exchangeable across populations. For example, suppose we have two treatment levels (xo, xl), a strongly ignorable assignment mechanism, and (as above) we label the xl-and xo-treated groups by A and B; then, absent any other information related to pAO or pB1, the pair (pA1, pAO) should be exchangeable with the pair (pB1, pBO).
For most purposes, however, only componentspecific exchangeability of pAl with p~~ or ~A O with ~B O is needed Robins, 198713) ; this condition is implied by but does not imply "weak ignorability," in which condition (1) above is replaced by the condition that X is independent of each component of y considered separately, rather than jointly (Stone, 1993) . Ignorability (strong or weak) is thus stronger than needed for identification of the causal parameter PA1 -~A O . Rubin (1991) has referred to an assignment mechanism that satisfies condition (1)(i.e., assigns treatment independently of y) as "unconfounded." Following Fisher (1935) , we prefer to call such a mechanism "unbiased," because traditional usage of "unconfounded refers to the actual allocation produced by the mechanism. Rubin's usage, like Stone's (1993) definition of "no confounding," does not allow for random allocation errors; as discussed earlier for randomization, however, random variation in unbiased mechanisms can by chance produce confounded allocations.
CONCLUSION
Concepts of confounding have been discussed by philosophers and scientists for centuries. It is only in more recent decades, however, that precise formal definitions of these concepts have emerged within statistical theory. These developments have revealed the distinction between counterfactual and collapsibility-based concepts of confounding. This distinction deserves mention in basic statistics education, because the counterfactual definition of confounding is nonparametric and specific to causal inference, whereas collapsibility depends on the choice of association parameter and requires no reference to causality or effects.
Our discussion has assumed that both the treatment variable and the confounders can be fully characterized by fixed covariates. Further subtleties can arise when these variables are time-dependent; see Robins (1986 Robins ( , 1987a Robins ( , b, 1997 and Pearl and Robins (1995) . We also have not considered issues of confounding in separating direct and indirect effects; for discussions, see Robins (1986 Robins ( , 1997 , Greenland (1992, 1994) , Pearl and Robins (1995) and Pear1 (1997) .
We wish to end on the cautionary note that confounding is but one of many problems that plague studies of cause and effect. Biases of comparable or even greater magnitude can arise from measurement errors, selection (sampling) biases, and systematically missing data, as well as from model-specification errors. Even when confounding and other systematic errors are absent, individual causal effects will remain unidentified by statistical observations (Greenland and Robins, 1988; Robins and Greenland, 1989) . It remains a serious challenge to create a statistical theory that can encompass all these problems coherently and also yield practical methods for data analysis.
APPENDIX 1: RESTRICTIONS IMPOSED BY THE POTENTIAL-OUTCOMES APPROACH
First, causal effects are defined only for comparisons of treatment levels. To state that "drinking two glasses of wine a day lengthened Smith's life by four years" is meaningless by itself. A reference level (e.g., no wine at all) must be at least implicit to make sense of the statement. Smith might have lived even longer had she consumed one rather than two glasses per day, in which case the statement would be false relative to one glass a day. As given, the statement could refer to no wine or four glasses per day or any other possibility.
Second, the definition assumes that yik, the outcome of unit i under treatment k, remains conceptually meaningful even if unit i is not given treatment k. That is, the analyst must be prepared to treat yio,. . . ,yiK as parameters unaffected by treatment assignment. Treatment assignment only determines which one of these K + 1 parameters we observe [that is, the realization of Yi (Rubin, 1974 (Rubin, , 1978 (Rubin, , 1991 l; the other K parameters remain latent traits of individual i . In the philosophy literature, analysis of this assumption is one of the core tasks of counterfactual logic (Simon and Rescher, 1966; Lewis, 1973a; Galles and Pearl, 1998 ; see also the discussion of Holland, 1986) . The statement "if xk had been administered, the response Yi of unit i would have been yik" is called a counterfactual conditional (Lewis, 1973b; Stalnaker, 1968) ; it asserts that Yi would have equaled yik if xk had been administered to unit i , even if xk had not i n fact been administered to unit i .
Third, the effects captured by the above counterfactual definition are net effects, in that they include all indirect effects and interactions not specifically excluded by treatment definitions. For example, Smith's consumption of two glasses of wine per day rather than none may have given her four extra years of life solely because one night at a formal dinner it made her feel unsteady and she had a friend drive her home; had she not drunk, she would have driven herself, skidded on a patch of ice, hit a tree and been killed. This sort of indirect effect is not one we would wish to capture when studying biologic ef-fects of wine use. It is nonetheless included in our measure of effect (as well as any estimate) unless we amend our treatment definition to include holding constant all "risky" activities that take place during Smith's life. Such an amendment is sometimes (simplistically) subsumed under the clause of "all other things being equal (apart from treatment)," but can be a serious source of ambiguity when the intervention that enforces the amendment is not well defined.
Consider next an illustration in which redefinition of the treatment is not an option. Suppose the objective is to estimate the effect of coffee use on risk of myocardial infarction (MI). If coffee had not been used by members of a cohort of current users, some of these members might have instead taken up or increased smoking to achieve their desired level of stimulation. Thus, coffee use may well have prevented or reduced smoking and so indirectly reduced MI risk. Would we want this indirect effect of coffee included in our target effect parameter? The answer to this question depends on the research goals, rather than statistics. If the answer is no-we wish only to estimate direct physiologic effect of coffee use, apart from its influence on smoking habitswe would have to redefine our reference level to one of no increased smoking, as well as no coffee use.
A fourth restriction, which may be considered an aspect of the third, is that the definition assumes that treatments not applied to a unit could have been applied. Suppose Smith would not and could not stop daily wine consumption unless forced physically to do so. The effect of her actual two-glassa-day consumption versus the counterfactual "no wine" would now be undefined without amending the treatment definition to include forcing Smith to drink no wine, for example, by removing all alcohol from public availability.
Some authors account for the preceding restriction by requiring that the counterfactual definition of "effect" applies only to "treatment variables." The latter are defined informally as variables subject to intervention or to manipulation of their levels (e.g., see Holland, 1986) . One may sense an echo of the circularity (as in ordinary definitions of cause and effect), for the notion of manipulation embodies having an effect on treatment levels (i.e., on xK) and is itself somewhat ambiguous. Further ambiguity arises because ordinary and useful notions of cause do not impose such restrictions; for example, the statement "trisomy 21 causes Down's Syndrome" is meaningful, even though no method for intervention on trisomy 21 is known. Nonetheless, it has been argued that one strength of the counterfactual approach is its explication of the ambiguities inherent in defining cause and effect (Lewis, 1973a; Holland, 1986; Rubin, 1990) . Although some authors impose no restrictions on the definition of cause (e.g., Lewis, 1973a) , in our presentation we assume that we are dealing only with causes that can be manipulated, such as drug treatments.
Implicit in most discussions of potential outcomes, including the present one, is that the outcome yik of unit i under treatment xk does not depend on the treatment given to any other unit. This postulate is often called the assumption of no interference among units, or the stability assumption (Cox, 1958; Rubin, 1978 Rubin, , 1990 . Chapter 2 of Cox (1958) gives a careful discussion of conditions that lead to interference in experimental trials. In epidemiologic studies, interference arises readily when the outcome is contagious; here, phenomena such as herd immunity may lead to complex dependencies of subjectspecific outcomes on the entire population distribution of treatment. In such situations, the potential outcomes of a single unit must at least be written yi,, where w ranges over all (K +l) N possible allocations of the K + 1treatments among the N population units; further complexities arise if dependencies among the unit specific outcomes must be directly modeled (Halloran and Struchiner, 1995) .
APPENDIX 2: DEFINING POTENTIAL OUTCOMES WHEN COMPETING RISKS ARE PRESENT
The definition of potential outcomes can be especially difficult in survival analysis when competing risks are present. Consider again Smith's drinking. Suppose she contracted cancer at age 70 and drank two glasses of wine a day, but would have instead died of a myocardial infarction at age 68 if she had drunk no wine. How could we define her counterfactual age-at-cancer given no wine? Without such a definition, the effect of two glasses of wine versus none would be undefined.
One school of thought maintains that, to offer a definition, one must have an unambiguous concept of the manner in which competing risks would be removed, as well as the counterfactual time of the outcome event. These requirements are not met by conditioning on "absence of competing risks": Such hypothetical absence is itself not a treatment or other well-defined counterfactual state, even though standard probability calculations (as used in product-limit estimates) make it appear otherwise (Kalbfleisch and Prentice, 1980, page 166; Prentice and Kalbfleisch, 1988) . To deal with this problem, one must specify a treatment that would prevent the competing risks, as well as the treatment xk of primary interest.
An opposing view maintains that it can be scientifically useful to assume that a potential outcome yik remains a well-defined quantity even if a competing risk would occur and prevent its observation under treatment xh (Robins, 1986 (Robins, , 1987a Slud, Byar and Schatzkin, 1988) . In such a case, yik is the time the outcome would have occurred if no competing risks occurred before yik. That is, we imagine that the causal mechanism leading to the outcome would have taken its course to a particular value yik had it not been interrupted by the competing risk. Returning to our example, we could imagine that, if Smith had drunk no wine, her pathophysiologic state at age 68 (when she died from a myocardial infarction) would have been such as to produce a malignant tumor after just one more year. Under this admittedly very hypothetical scenario, we could say that her drinking extended her age-at-cancer by one year because she in fact contracted cancer at age 70. Note that this latent-outcome model does not imply that the competing risks are independent.
A third approach to the competing-risk problem is based on extending the ordinary definitions of effect in absence of competing risks to encompass instances in which the outcome is undefined under one or more treatments. For details, see Robins (1995b) .
